Dear Colleague:
Based on your involvement with obesity, MedMarket Diligence would like to alert 
you to a forthcoming report (to be published by September 15, 2007) on the 
"Worldwide Market for the Clinical Management of Obesity, 2007-2015."
This report is available for purchase with a pre-publication discount of $500 
off the regular price of $4,250, but I wanted to add another $250 discount for 
individuals such as yourself in the field of obesity.
You may order online or by order form (be certain to note discounts on the 
form).  The $500 discount expires when the report publishes, but the extra $250 
off will be available through September 30, 2007.  To get the extra $250 off, 
use the coupon code "1189270878" or "bariatric07" on checkout from the online 
store or just note it on the PDF order form.
Below is a brief description of the report:
The MedMarket Diligence report on obesity, "Worldwide Market for the Clinical 
Management of Obesity, 2007-2015," is a detailed market and technology 
assessment and forecast of the products and technologies in the clinical 
management of obesity. The report describes the current and projected patient 
population in obesity, detailing their incidence in the U.S., Europe, and Rest 
of World, and the clinical practices in obesity management encompassing 
surgical approaches, medical supervised severely restricted diets, drug 
therapies, OTC treatments, biopharmaceuticals, non-pharmacologic approaches and 
weight maintenance approaches. The report describes clinical trends in the 
management of the obese. The report details the products on the market and the 
status of those in development for bariatric surgery, drug therapy, gastric 
stimulation devices, brain stimulation devices, combination therapies and 
genetic therapy, and provides current and forecast of the market for these 
products in the U.S., Europe and Rest of World. The report profiles key 
companies in the market, detailing the current products, products in 
development, market position and overall businesses in obesity management.
The report is described in detail, with a complete table of contents and list 
of exhibits, here.
MedMarket Diligence provides tactical information and insight to the medical 
products, investment and other industries on the status and outlook for 
advanced medical technologies. The company publishes MedMarkets, a range of 
medical technology market and assessment  Reports and the new Medtech Startups 
Database.
Feel free to contact us if you have any additional questions.
Kind regards,
Patrick Driscoll
Publisher
MedMarket Diligence, LLC
51 Fairfield
Foothill Ranch, CA 92610 USA
(949) 859-3401
(949) 837-4558 fax
Toll-free (US): 1-866-820-1357 
www.medilgence.com



This is an advertisement.
You have received this Email because MedMarket Diligence would like to offer 
services to you. To avoid future contact, please e-mail [EMAIL PROTECTED] or 
reply to this e-mail with the word "unsubscribe" as the subject line of your 
message. Your request will be honored; we do not buy or sell email addresses. 
Thank you.
We fully comply with the CAN-SPAM Act of 2004.
The CAN-SPAM Act went into effect January 1, 2004. We strongly encourage you to 
review the entire contents of the Act by clicking here:
http://www.ftc.gov/bcp/conline/pubs/buspubs/canspam.htm

Odpowiedź listem elektroniczym